Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Clinical trial NCT05122182 · TERMINATED
Trial details
- NCT number
- NCT05122182
- Sponsor
- University of Sydney
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-07
- Primary completion
- 2022-08-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.